Growth drug shows promise for kids with rare short stature
NCT ID NCT04219007
First seen Apr 28, 2026 · Last updated May 24, 2026 · Updated 6 times
Summary
This study tests a drug called vosoritide in children with short stature caused by certain genetic conditions. The drug targets the growth plate to help bones grow. Over 12 months, researchers will measure how much children grow and check for side effects. The goal is to see if vosoritide can safely improve height in these children.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SHORT STATURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's National Hospital
Washington D.C., District of Columbia, 20010, United States
Conditions
Explore the condition pages connected to this study.